人民卫生出版社系列期刊
ISSN 2096-2738 CN 11-9370/R

中国科技核心期刊(中国科技论文统计源期刊)
2020《中国学术期刊影响因子年报》统计源期刊

新发传染病电子杂志 ›› 2023, Vol. 8 ›› Issue (5): 63-74.doi: 10.19871/j.cnki.xfcrbzz.2023.05.013

• 指南与共识 • 上一篇    下一篇

耐药肺结核影像学诊断专家共识

1.中国研究型医院学会感染与炎症放射学专业委员会;2.中华医学会放射学分会传染病学组;3.中国科技产业化促进会数字健康专业委员会;4.中国性病艾滋病防治协会艾滋病影像学专业委员会;5.中国医院协会传染病医院分会传染病影像学组;6.北京影像诊疗技术创新联盟;7.中国医药质量管理协会医学影像质量研究委员会   

  • 收稿日期:2023-08-15 出版日期:2023-10-31 发布日期:2023-12-05
  • 通讯作者: 李宏军,Email:lihongjun00113@ccmu.edu.cn;陆普选, Email:lupuxuan@126.com
  • 基金资助:
    1. 国家重点研发计划项目(2019YFE01214001); 2. 深圳市基础研究资助项目(JCYJ20190813153413160); 3. 广州市科技重点研发计划(2023B03J1303); 4. 广州市科技市校(院)企联合资助项目(2023A03J0994); 5. 重庆市科卫联合医学科研项目(2023DBXM005); 6. 南京市卫生科技发展专项基金项目(YKK21126); 7.南京医学会放射学分会医学影像人工智能专项研究基金面上项目(2023015)

Expert consensus on imaging diagnosis of drug-resistant pulmonary tuberculosis

1. Infectious Disease Imaging Group of Chinese Hospital Association Infectious Diseases Hospitals Branch;2. Infectious Diseases Group of Chinese Medical Association of Radiology;3. Digital Health Committee of China Association for the Promotion of Science, Technology Industrialization;4. Committee of AIDS Imaging of China STD, AIDS Prevention Association;5. Infectious Diseases Group, General Radiological Equipment Committee, China Association of Medical Equipment;6. Beijing Imaging Diagnosis, Treatment Technology Innovation Alliance;7. Medical Imaging Quality Research Committee, China Quality Association for Pharmaceuticals   

  • Received:2023-08-15 Online:2023-10-31 Published:2023-12-05

摘要: 结核病(TB)仍是全球重大传染病之一,发病率居高不下,而耐药肺结核(DR-PTB)更是结核病防治中的重点和难点。DR-PTB的早期、快速、准确诊断对于选择适当和个性化治疗方案至关重要,也是减少疾病传播和降低死亡率的重要手段。近年来DR-PTB的影像学诊断研究发展迅速,但缺乏一致性认识。为此,中国研究型医院学会感染与炎症放射学专业委员会、中华医学会放射学分会传染病学组及中国科技产业化促进会数字健康专业委员会等牵头组织国内从事结核病临床及影像学研究的相关专家,参考国际国内DR-PTB的诊疗现状,结合我国临床实践和循证医学指南及标准的方法学要求,经反复讨论形成DR-PTB影像学诊断专家共识。其内容包括DR-PTB的临床诊断与分型、病原学及影像学检查的优选、影像学表现及诊断与鉴别诊断。以期通过该专家共识提高临床及影像医生对DR-PTB影像学改变的认识,及时发现可疑DR-PTB患者,有效提高临床诊断效率,达到对DR-PTB早期诊治的目的 。

关键词: 肺结核, 耐药, 体层摄影术, 影像学诊断, 专家共识

Abstract: Tuberculosis (TB) is still one of the major infectious diseases in the world, and the incidence of Drug-resistant pulmonary tuberculosis (DR-PTB) is the focus and difficulty of tuberculosis control. Early, rapid and accurate diagnosis of DR-PTB is essential for selecting appropriate and personalized treatment and is an important means of reducing disease transmission and mortality. In recent years, the imaging diagnosis of DR-PTB has developed rapidly, but there is a lack of consistent understanding. To this end, Infectious Disease Imaging Group, Infectious Disease Branch, Chinese Research Hospital Association; Infectious Diseases Group of Chinese Medical Association of Radiology Digital Health Committee of China Association for the Promotion of Science and Technology Industrialization.et.led the organization of tuberculosis clinical and imaging experts across the country, referring to the diagnosis and treatment status of DR-PTB at home and abroad, combined with China's clinical practice and evidence-based medicine on the methodological requirements of guidelines and standards. After repeated discussion, the expert consensus of imaging diagnosis of DR-PTB was formed. Its contents include clinical diagnosis and classification of DR-PTB, selection of etiology and imaging examination, imaging manifestations, diagnosis and differential diagnosis. This expert consensus is expected to improve the understanding of the imaging changes of DR-PTB, as a starting point for timely detection of suspected DR-PTB patients, and can effectively improve the efficiency of clinical diagnosis and achieve the purpose of early diagnosis and treatment of DR-PTB.

Key words: Pulmonary tuberculosis, Drug resistance, Tomography, Imaging diagnosis, Expert consensus

中图分类号: